TCL Archive Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer September 25, 2009
TCL Archive Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted September 6, 1974
TCL Archive Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes February 28, 2014
TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
